Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Hanan Henidi

7PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targetsBiologically active moleculesShip and platform structures (incl. maritime hydrodynamics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

Sort by Publication Date:
|Nov 27, 2025
Thymoquinone Overcomes Hypoxia-Induced Carboplatin Resistance Through ROS-Independent Apoptosis but Promotes Cancer Stem Cell Enrichment: Implications on Oral Cancer Adaptation and Recurrence.

Ishrat Rahman, Hanan Henidi, Manal M Alkahtani

|Nov 27, 2025
Cuproptosis Contributes to Cisplatin-Induced Nephrotoxicity: Insights into Thymol's Potential Inhibitory and Protective Effects.

Layla A Al-Kharashi, Amira M Badr, Reem T Atawia

|Sep 27, 2025
Thymol Preserves Spermatogenesis and Androgen Production in Cisplatin-Induced Testicular Toxicity by Modulating Ferritinophagy, Oxidative Stress, and the Keap1/Nrf2/HO-1 Pathway.

Amira M Badr, Sheka Aloyouni, Yasmin Mahran

|Aug 28, 2025
From Hue to Health: Exploring the Therapeutic Potential of Plant-Pigment-Enriched Extracts.

Azza SalahEldin El-Demerdash, Amira E Sehim, Abeer Altamimi

|Dec 17, 2024
Natural Inhibitors of <i>Salmonella</i> MDR Efflux Pumps AcrAB and AcrD: An Integrated In Silico, Molecular, and In Vitro Investigation.

Azza S El-Demerdash, Shimaa A Kamel, Eman Y T Elariny

|Sep 28, 2023
Cytotoxic Potential of Novel Quinoline Derivative: 11-(1,4-Bisaminopropylpiperazinyl)5-methyl-5H-indolo[2,3-b]quinoline against Different Cancer Cell Lines via Activation and Deactivation of the Expression of Some Proteins.

Sara Fathy Abd Elrahman, Abdullah A S Ahmed, Doaa Abd Elsatar

Pageof 2

Frequent Collaborators

4 joint publications

Elshaymaa I Elmongy

2 joint publications

Azza SalahEldin El-Demerdash

2 joint publications

Amira M Badr

1 joint publications

Abdullah A S Ahmed

1 joint publications

Fatma Alnakeeb

1 joint publications

Mabrouk Attia Abd Eldaim

1 joint publications

Hadil Alahdal

1 joint publications

Abdulrahman M Saleh

1 joint publications

Rehab A Ibrahim

1 joint publications

Amira E Sehim

Frequent Collaborators

4 joint publications

Elshaymaa I Elmongy

2 joint publications

Azza SalahEldin El-Demerdash

2 joint publications

Amira M Badr

1 joint publications

Abdullah A S Ahmed

Top Related Videos

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on : Sep 10, 2014

13.9K
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on : Mar 16, 2018

9.9K
See more related videos

Top Related Videos

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on : Sep 10, 2014

13.9K
Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity
09:52

Trans-Tympanic Drug Delivery for the Treatment of Ototoxicity

Published on : Mar 16, 2018

9.9K
See more related videos